GLOBAL biopharmaceutical firm
A. Menarini has today announced
the official Australian launch of
Priligy (dapoxetine), which is the
first and only drug specifically
developed for the treatment of
premature ejaculation.
It’s TGA approved for the
treatment of PE in men 18-64, and
acts by inhibiting the serotonin
reuptake transporter system.The above article was sent to subscribers in Pharmacy Daily's issue from 01 Jul 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 01 Jul 13
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.